Hakon Blomstrand

Publications

2023

Hakon Blomstrand, Hans Olsson, Henrik Green, Bergthor Björnsson, Nils Elander (2023) Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort study HPB, Vol. 25, p. 1531-1544 Continue to DOI

2021

Hakon Blomstrand, Atul Batra, Winson Y. Cheung, Nils Elander (2021) Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer World Journal of Clinical Oncology, Vol. 12, p. 787-799 Continue to DOI
Hanna Lagenfelt, Hakon Blomstrand, Nils Elander (2021) Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer Cancers, Vol. 13, Article 3507 Continue to DOI

2020

Hakon Blomstrand, Karin Adolfsson, Per Sandström, Bergthor Björnsson (2020) Complete Radiologic Response of Metastatic Pancreatic Ductal Adenocarcinoma to Microwave Ablation Combined with Second-Line Palliative Chemotherapy Case Reports in Gastrointestinal Medicine, Vol. 2020, Article 4138215 Continue to DOI
Hakon Blomstrand, Henrik Green, Mats Fredrikson, Emma Gransmark, Bergthor Björnsson, Nils Elander (2020) Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel BMC Cancer, Vol. 20, Article 950 Continue to DOI
Emma Gränsmark, Nellie Bågenholm Bylin, Hakon Blomstrand, Mats Fredrikson, Elisabeth Åvall Lundqvist, Nils Elander (2020) Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer Frontiers in Oncology, Vol. 10, Article 1176 Continue to DOI

2019

Hakon Blomstrand, Ursula Scheibling, Charlotte Bratthall, Henrik Green, Nils Elander (2019) Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer BMC Cancer, Vol. 19, Article 40 Continue to DOI

Research